The European Region was certified polio-free
On Jun. 21, 2002, all 53 Member States in the WHO European Region were certified polio free by…
On Jun. 21, 2002, all 53 Member States in the WHO European Region were certified polio free by…
On May 14, 2002, the Food and Drug Administration (FDA) approved for use an additional combined diphtheria and…
On Feb. 25, 2002, GlaxoSmithKline announced that the company would no longer manufacture or distribute its Lyme disease…
In 2002, the Rotary International launched a Polio Eradication Fundraising Campaign with a fundraising target of $80 million…
On Nov. 5, 2001, following the events of September 11, the Institute of Medicine again called for creation…
On Sept. 11, 2001, the U.S. Centers for Disease Control and Prevention (CDC) learned of a domestic terrorism…
On May 11, 2001, the Food and Drug Administration (FDA) licensed a combined hepatitis A and B vaccine…
In 2001, The Bill and Melinda Gates Foundation earmarked $70 million to develop and produce meningitis vaccines tailored…
On Dec. 21, 2000, Dr. Peter St George-Hyslop developed a vaccine that prevented Alzheimer’s disease in mice. The…
On Oct. 29, 2000, the Regional Commission for the Certification of Poliomyelitis Eradication certified that the Western Pacific…
On May 25, 2000, the National Institute of Allergy and Infectious Diseases (NIAID) announced funding of nine U.S….
On Feb. 17, 2000, the Food and Drug Administration (FDA) announced it it had licensed a 13-valent pneumococcal…
In 2000, the use of Oral polio vaccine (OPV) was discontinued in the U.S. to eliminate the risk…
In 2000, measles was declared no longer endemic in the U.S. following eradication campaigns that began in 1967….
On Dec. 9, 1999, the diphtheria and tetanus toxoids and acellular pertussis vaccine (Tripedia by Connaught) was licensed….
On Nov. 23, 1999, the Bill & Melinda Gates Foundation pledged a gift of $750 million over five…
On Oct. 22, 1999, the Advisory Committee on Immunization Practices (ACIP), after a review of scientific data from…
On Oct. 15, 1999, Wyeth-Lederle Vaccines announced that it was withdrawing the Rotashield vaccine from the market and…
In August 1999, an outbreak of encephalitis caused by West Nile virus (WNV) was detected in New York…
On Jun. 17, 1999, the Immunization Practices Advisory Committee (ACIP) recommended exclusive use of inactivated poliovirus vaccine (IPV)…
On Jun. 9, 1999, the Dale and Betty Bumpers Vaccine Research Center (VRC) was established at the National…
In April 1999, a pandemic planning framework was published by the World Health Organization (WHO) that emphasized the…
On Jan. 15. 1999, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
In 1999, a meningococcal group C conjugate vaccine was introduced into the routine schedule in the U.K. for…
In 1999, the U.S. Centers for Disease Control and Prevention (CDC) launched the National Pharmaceutical Stockpile, now the…
In 1999, the U.S. Centers for Disease Control and Prevention (CDC) established the Laboratory Response Network (LRN). The…
On Dec. 21, 1998, the Lyme Disease Vaccine (Recombinant OspA), (LYMErix by SmithKline Beecham) was licensed for use…
On Aug. 31, 1998, Rotashield (Wyeth Laboratories, Marietta, Pennsylvania) was licensed by the U.S. Food and Drug Administration…
On Aug. 26, 1998, the Children’s Vaccine Program was established at WHO’s Program for Appropriate Technology in Health…
On Jul. 29, 1998, the diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Certiva by North American…